thymidine has been researched along with Aggressive Systemic Mastocytosis in 1 studies
Aggressive Systemic Mastocytosis: A form of systemic mastocytosis in which patients have impaired organ functions due to multifocal infiltrates of pathological MAST CELLS in bone marrow, liver, spleen, gastrointestinal tract, or skeletal system. The cytomorphology shows a low to high grade.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peter, B | 1 |
| Gleixner, KV | 1 |
| Cerny-Reiterer, S | 1 |
| Herrmann, H | 1 |
| Winter, V | 1 |
| Hadzijusufovic, E | 1 |
| Ferenc, V | 1 |
| Schuch, K | 1 |
| Mirkina, I | 1 |
| Horny, HP | 1 |
| Pickl, WF | 1 |
| Müllauer, L | 1 |
| Willmann, M | 1 |
| Valent, P | 1 |
1 other study available for thymidine and Aggressive Systemic Mastocytosis
| Article | Year |
|---|---|
Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536.
Topics: Animals; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Resp | 2011 |